FDA+ channel feed – Endpoints News

FDA+ channel feed

Purdue’s emergency opioid overdose treatment is approved by the FDA

9 months ago

FDA approves Citius Pharma's non-Hodgkin lymphoma drug Lymphir

9 months ago

Amneal Pharma's extended-release Parkison's treatment clinches FDA approval

9 months ago

FDA approves Novartis’ complement inhibitor Fabhalta for rare kidney disease

9 months ago

FDA reprimands Bristol Myers over misleading efficacy claims on Krazati website

9 months ago

FDA grapples with its role in AI, and how to guide industry's adoption

9 months ago

Inspection delays hold back BeiGene's Tevimbra progress once again

9 months ago

Updated: FDA approves Servier’s brain cancer drug, setting up $1B payout for Agios

9 months ago

CDC chief says new RSV guidance was meant to be ‘clear’ and ‘actionable’

9 months ago

Doses of Lilly's blockbuster GLP-1 in shortage have been pulled from FDA supply list

9 months ago

Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer

9 months ago

GSK scores expanded label for Jemperli in first-line endometrial cancer

9 months ago

Judge rejects Novo Nordisk's IRA case as pricing negotiations conclude

9 months ago

FDA questions Zevra’s resubmitted data for rare disease drug ahead of adcomm

9 months ago

Vertex gets January decision date for non-opioid pain medicine

9 months ago

Filing a new drug with clinical data in 2025? FDA sets fee at $4.3M

9 months ago

FDA shoots down second Novartis petition seeking to halt Entresto generics

9 months ago

AstraZeneca and Daiichi Sankyo fail to win NICE recommendation for Enhertu, call for change to review process

9 months ago

FDA's ad enforcer critiques Brittany Mahomes' paid Instagram post for Kaléo

9 months ago

vTv Therapeutics' diabetes drug program hit with clinical hold from FDA

9 months ago

Compounded weight loss drugs have resulted in misdosing, hospitalizations, FDA warns

9 months ago

Among pharma CEOs, the IRA now and the IRA later get very different reactions

9 months ago

FDA approves Sun Pharma's JAK inhibitor Leqselvi for hair loss in adults

9 months ago

FDA advisors call for better studies of immunotherapy around lung cancer surgery, but give AstraZeneca a pass

9 months ago

First page Previous page 17 18 192021 22 23 Next page Last page